The clinical implications of our findings establish NMUR2 as a novel regulator of binge-type eating and therefore as a potential druggable candidate for the overconsumption behavior observed in BED and obesity. The gene discussed is NMUR2; the disease is obesity due to melanocortin 4 receptor deficiency.